Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Therapy for IC in Generalized Vulvodynia
NCT01048177Phase 2Withdrawn
- Sponsor
- Scripps Health
- Start
- Dec 2012
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin, lidocaine in vulvodynia, sponsored by Scripps Health. Planned start Dec 2012; status: withdrawn.
02
Drugs
heparinlidocaine
03
Conditions
vulvodynia
Beyond the preview
Go deeper on NCT01048177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01048177.